The University of Tennessee’s Research Foundation recently executed a license granting CytoSen Therapeutics Inc. the commercial rights to use the K-562 cell lines to produce an innovative natural killer cell therapy that harnesses the power of a person’s own immune cells to help fight cancer. Read more here.
Tennessee Valley Corridor National Summit
- UT Chattanooga
- May 29 2019
"HealthTech Accelerator Demo Day"
- Jun 05 2019
"Workforce Opportunity for Rural Communities Initiative" Workshop
- Carnegie Hotel, Johnson City
- Jun 06 2019
"SBIR/STTR Resources for Entrepreneurial Researchers" Workshop
- UTRF Offices, Room 126 Strong Hall, 1621 West Cumberland Avenue, Knoxville
- Jun 21 2019
Bunker Labs' "Muster Across America Tour"
- Aug 08 2019